NASDAQ:BIOX Bioceres Crop Solutions Q1 2027 Earnings Date & Estimates $0.23 -0.02 (-8.00%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$0.23 0.00 (-1.11%) As of 10/23/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Bioceres Crop Solutions is estimated to report Q1 2027 earnings on Thursday, November 12, 2026. The conference call is scheduled for 8:30 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ1 2027Announcement DateNovember 12, 2026Conference Call8:30 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Bioceres Crop Solutions in Q1 2027Bioceres Crop Solutions is expected to post earnings of $0.02 per share. Bioceres Crop Solutions last reported on September 15, 2026, posting -$0.39 per share and missing the -$0.06 consensus estimate. Bioceres Crop Solutions has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.02Recent Track RecordLast ReportedQ4 2026Last Quarter EPS-$0.39 (Missed by -$0.33)Last Quarter Revenue$55.90 millionEPS Beat Rate2 of last 8 quartersPrepare for the Q1 2027 CallEarnings HistoryCompany ProfileQ4 2026 Earnings ReportQ3 2026 Earnings ReportQ2 2026 Earnings Report Bioceres Crop Solutions Q1 2027 Earnings FAQ When does Bioceres Crop Solutions report Q1 2027 earnings? Bioceres Crop Solutions (NASDAQ:BIOX) is estimated to report Q1 2027 earnings on Thursday, November 12, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Bioceres Crop Solutions' Q1 2027 earnings call? Bioceres Crop Solutions' Q1 2027 earnings conference call is scheduled for Thursday, November 12, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Bioceres Crop Solutions? Analysts expect Bioceres Crop Solutions to post earnings of $0.02 per share for Q1 2027. Bioceres Crop Solutions Earnings HeadlinesReviewing Flotek Industries (NYSE:FTK) and Bioceres Crop Solutions (NASDAQ:BIOX)October 24 at 4:21 AM | americanbankingnews.comBioceres (BIOX) Q4 2026 Earnings Call TranscriptSeptember 15, 2026 | finance.yahoo.comThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.October 25 at 1:00 AM | Porter & Company (Ad)Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating ResultsSeptember 14, 2026 | businesswire.comBioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern TimeSeptember 9, 2026 | businesswire.comBioceres Crop Solutions Corp (BIOX) Q3 2026 Earnings Call Highlights: Navigating Challenges ...May 14, 2026 | finance.yahoo.comSee More Bioceres Crop Solutions Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bioceres Crop Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bioceres Crop Solutions and other key companies, straight to your email. Email Address About Bioceres Crop SolutionsBioceres Crop Solutions (NASDAQ:BIOX) (NASDAQ:BIOX) is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. Its offerings include genetically enhanced seeds, biological crop inputs, seed treatments, biostimulants, fertilizers and crop protection products designed for use across major field crops. The company is best known for its HB4 technology, a drought-tolerance trait developed for wheat and soybeans. Bioceres has also developed biological products, including microbial inoculants and other solutions intended to improve nutrient use and plant performance. Its product portfolio is marketed primarily through agricultural distribution channels and serves farmers in Argentina and other markets across the Americas, as well as selected international regions. Bioceres traces its roots to Argentina’s agricultural biotechnology sector and expanded its portfolio through the integration of businesses such as Rizobacter, an established producer of biological and crop-input products. The company is led by Chief Executive Officer Federico Trucco, who has been involved in the development and commercialization of its agricultural biotechnology platform.View Bioceres Crop Solutions ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a PipelineNewmont’s Record Quarter Shows Why Gold’s Floor Is the Real StoryLockheed Martin’s Record $292 Billion Backlog Comes With a Delivery TestCan Planet Fitness Get Its Growth Back in Shape?Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs Upcoming Earnings Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Coca Cola Femsa (10/27/2026)Baker Hughes (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
